ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01CR02 | G | Amoxicillin - 600mg/5ml, Clavulanic Acid - 42.9mg/5ml | 10860 | 28820/1 | BETAMOX ES | 100ml | Powder for suspension | Oral | Pharmamedic S.A.R.L. | Laboratorios Atral SA | Portugal | 592,635 L.L | 23.08 | A1 | Laboratorios Atral SA | Portugal | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01CR02 | B | Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml | 6251 | 166503/11 | AUGMENTIN ES | 642.9mg/5ml | 100ml | Powder for suspension | Oral | Abela Frères S.A.L. | GlaxoWellcome Production | France | 846,621 L.L | 23.08 | A2 | GlaxoSmithKline Produtos Farmaceuticos Lda | Portugal | 2/5/2024 | 0 |
J01CR02 | G | Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml | 5384 | 221974/09 | AMOCLAN BID | 642.9mg/5ml | 75ml | Powder for suspension | Oral | Droguerie de l'Union | Hikma Pharmaceuticals | Jordan | 507,972 L.L | 23.08 | A1 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
J01CR02 | G | Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml | 7025 | 96599/12 | JULMENTIN ES | 642.9mg/5ml | 100ml | Powder for suspension | Oral | Pharmanet Drugstore S.A.R.L. | Julphar | United Arab Emirates | 507,972 L.L | 23.08 | A1 | Julphar | United Arab Emirates | 2/5/2024 | 0 |
J01CR02 | G | Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml | 11609 | 132320/0 | MEGAMOX-JPI ES | 600mg | 100ml | Powder for suspension | Oral | Droguerie de l'Union | Jazeera Pharmaceutical Industries | Saudi Arabia | 507,972 L.L | 23.08 | A1 | Jazeera Pharmaceutical Industries | Saudi Arabia | 2/5/2024 | 0 |